Dosage and administration
• instill 1 or 2 drops in the affected eye(s) every 3 to 4 hours, or as directed by a doctor.
• instill 1 or 2 drops in the affected eye(s) every 3 to 4 hours, or as directed by a doctor.
Walgreen’s Sodium Chloride Ophthalmic
Solution, 5% Hypertonicity Eye Drops 15mL
NDC 0363-0193-13
Drug Facts
Sodium Chloride 5%
Hypertonicity Agent
• For the temporary relief of corneal edema.
For use in the eyes only
Save box for complete information
• except under the advice and supervision of a doctor.
• if solution changes color or becomes cloudy.
• keep tightly closed.
• to avoid contamination, do not touch tip of container to any surface.
• replace cap immediately after each use.
• this product may cause temporary burning and irritation on being instilled into the eye.
• you experience eye pain. • changes in your vision occur.
• continued redness or irritation of the eye persists.
• condition worsens or persists.
If swallowed, get medical help or contact a Poison Control Center right away.
• instill 1 or 2 drops in the affected eye(s) every 3 to 4 hours, or as directed by a doctor.
• replace cap after using and keep tightly closed.
• store at 15° to 30°C (59° to 86°F).
• remove contact lenses before using.
Boric Acid, Hypromellose, Methylparaben, Propylene Glycol, Propylparaben, Sodium Borate, and Water for injection. Sodium Hydroxide and/or Hydrochloric Acid may be added to adjust pH.
• 1-800-925-4733 • 9am – 5pm EST Monday - Friday
Walgreens
NDC 0363-0193-13
Sodium Chloride
Ophthalmic
Solution, 5%
Hypertonicity
Eye Drops
0.5 FL OZ (15 mL)
| Class | Version | Type | Effective |
|---|---|---|---|
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0311917214177 | GTIN-13: 0311917214177 EAN-13: 0311917214177 GTIN-12: 311917214177 UPC-A: 311917214177 GTIN storage (14 digits): 00311917214177 | Hypertonicity Eye Drops Carton.jpg, WAG_EE_662718_HypertonicityEyeDrops_BOX_TRPr3_F-OL.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0363-0193-13 | 2025-12-20 | C162847 | 48780-1 | 1e7a6dab-19f1-a2ce-e063-dadaa90aadf7 | Walgreens Sodium Chloride Ophthalmic Solution |
| 0363-0193-13 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-19f1-a2ce-e063-dadaa90aadf7 | Walgreens Sodium Chloride Ophthalmic Solution |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-0193-13 | Sodium Chloride | 15 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 15 | 7 | |
| 0363-0193-13 | Sodium Chloride | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 7 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0363-0193-13 | ML - Milliliter | 0363-0193 | 4efcbdfb-3131-47f0-9c61-e285f41878bb | 1 | 2022-06-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0363-0193 | 0363-0193-13 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BORIC ACID | R57ZHV85D4 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SODIUM BORATE | 91MBZ8H3QO | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Walgreen Company | d112a344-33cc-41d3-bae6-492631ebdba7 | 2025-11-19 | Warnings | 0363-0193-13 0363-0193 00363019313 43f4dd02-20e9-ee0b-e063-6294a90ad917 d112a344-33cc-41d3-bae6-492631ebdba7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.